137 related articles for article (PubMed ID: 27258084)
1. Drug Targets for Cardiovascular-Safe Anti-Inflammatory: In Silico Rational Drug Studies.
Shahbazi S; Sahrawat TR; Ray M; Dash S; Kar D; Singh S
PLoS One; 2016; 11(6):e0156156. PubMed ID: 27258084
[TBL] [Abstract][Full Text] [Related]
2. Diverse ways of perturbing the human arachidonic acid metabolic network to control inflammation.
Meng H; Liu Y; Lai L
Acc Chem Res; 2015 Aug; 48(8):2242-50. PubMed ID: 26237215
[TBL] [Abstract][Full Text] [Related]
3. Computational analysis of eugenol inhibitory activity in lipoxygenase and cyclooxygenase pathways.
das Chagas Pereira de Andrade F; Mendes AN
Sci Rep; 2020 Oct; 10(1):16204. PubMed ID: 33004893
[TBL] [Abstract][Full Text] [Related]
4. Rational Druggability Investigation Toward Selection of Lead Molecules: Impact of the Commonly Used Spices on Inflammatory Diseases.
Zakerali T; Shahbazi S
Assay Drug Dev Technol; 2018 Oct; 16(7):397-407. PubMed ID: 30106307
[TBL] [Abstract][Full Text] [Related]
5. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
6. N-Caffeoyl serotonin as selective COX-2 inhibitor.
Takahashi T; Miyazawa M
Bioorg Med Chem Lett; 2012 Apr; 22(7):2494-6. PubMed ID: 22386242
[TBL] [Abstract][Full Text] [Related]
7. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
[TBL] [Abstract][Full Text] [Related]
8. Anti-Inflammatory Activity of Novel 12-N-methylcytisine Derivatives.
Tsypysheva IP; Borisevich SS; Zainullina LF; Makara NS; Koval'skaya AV; Petrova PR; Khursan SL; Vakhitova YV; Zarudii FS
Antiinflamm Antiallergy Agents Med Chem; 2017; 16(2):112-122. PubMed ID: 28618989
[TBL] [Abstract][Full Text] [Related]
9. New hybrid molecules combining benzothiophene or benzofuran with rhodanine as dual COX-1/2 and 5-LOX inhibitors: Synthesis, biological evaluation and docking study.
El-Miligy MMM; Hazzaa AA; El-Messmary H; Nassra RA; El-Hawash SAM
Bioorg Chem; 2017 Jun; 72():102-115. PubMed ID: 28390993
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological screening of new 4-thiazolidinone derivatives with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile.
Abdellatif KR; Abdelgawad MA; Elshemy HA; Alsayed SS
Bioorg Chem; 2016 Feb; 64():1-12. PubMed ID: 26561742
[TBL] [Abstract][Full Text] [Related]
11. Novel diphenylthiazole derivatives with multi-target mechanism: Synthesis, docking study, anticancer and anti-inflammatory activities.
Abdelazeem AH; El-Saadi MT; Said EG; Youssif BGM; Omar HA; El-Moghazy SM
Bioorg Chem; 2017 Dec; 75():127-138. PubMed ID: 28938224
[TBL] [Abstract][Full Text] [Related]
12. Cardioprotective actions of curcumin on the pathogenic NFAT/COX-2/prostaglandin E
Hernández M; Wicz S; Corral RS
Phytomedicine; 2016 Nov; 23(12):1392-1400. PubMed ID: 27765359
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of in vitro and in vivo anti-inflammatory effects of (-)-pseudosemiglabrin, a major phytoconstituent isolated from Tephrosia apollinea (Delile) DC.
Hassan LE; Dahham SS; Fadul SM; Umar MI; Majid AS; Khaw KY; Majid AM
J Ethnopharmacol; 2016 Dec; 193():312-320. PubMed ID: 27553975
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase inhibitors: From pharmacology to clinical read-outs.
Patrignani P; Patrono C
Biochim Biophys Acta; 2015 Apr; 1851(4):422-32. PubMed ID: 25263946
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a novel COX-2 inhibitor as an orally potent anti-pyretic and anti-inflammatory drug: design, synthesis, and structure-activity relationship.
Hayashi S; Sumi Y; Ueno N; Murase A; Takada J
Biochem Pharmacol; 2011 Oct; 82(7):755-68. PubMed ID: 21741371
[TBL] [Abstract][Full Text] [Related]
16. Curcumin synergistically potentiates the growth-inhibitory and pro-apoptotic effects of celecoxib in osteoarthritis synovial adherent cells.
Lev-Ari S; Strier L; Kazanov D; Elkayam O; Lichtenberg D; Caspi D; Arber N
Rheumatology (Oxford); 2006 Feb; 45(2):171-7. PubMed ID: 16249246
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of novel triarylpyrazoline derivatives as selective COX-2 inhibitors.
Abdellatif KR; Abdelgawad MA; Labib MB; Zidan TH
Bioorg Med Chem Lett; 2015 Dec; 25(24):5787-91. PubMed ID: 26546221
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibitory activities and molecular docking studies of substituted 2-mercapto-4(3H)-quinazolinones.
Abdel-Aziz AA; Abou-Zeid LA; ElTahir KEH; Ayyad RR; El-Sayed MA; El-Azab AS
Eur J Med Chem; 2016 Oct; 121():410-421. PubMed ID: 27318118
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms involved in the anti-inflammatory effect of a standardized willow bark extract.
Khayyal MT; El-Ghazaly MA; Abdallah DM; Okpanyi SN; Kelber O; Weiser D
Arzneimittelforschung; 2005; 55(11):677-87. PubMed ID: 16366042
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, biological evaluation and docking study of a new series of di-substituted benzoxazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
Kaur A; Pathak DP; Sharma V; Wakode S
Bioorg Med Chem; 2018 Feb; 26(4):891-902. PubMed ID: 29373271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
